Position in BMY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$185,662,586
-$21,907,367 QoQ
Shares Held
3,222,190
-5.9% QoQ
Ownership
0.158%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#74
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aberdeen Group plc holds $3,276,463,441 across 12 Drug Manufacturers - General names. BMY ranks #5 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
682,818 | $818,992,461 | |
| 2 | JNJ |
Johnson & Johnson
|
2,447,058 | $621,479,319 | |
| 3 | MRK |
Merck & Co., Inc.
|
4,309,756 | $553,803,646 | |
| 4 | ABBV |
AbbVie Inc.
|
2,052,285 | $516,436,996 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
3,222,190 | $185,662,586 | |
| 6 | AMGN |
Amgen Inc
|
489,514 | $177,262,808 | |
| 7 | PFE |
Pfizer Inc
|
6,163,309 | $148,412,479 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,003,515 | $126,784,084 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $185,662,586 | 3,222,190 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $207,569,953 | 3,422,423 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $183,232,290 | 3,396,965 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $143,451,463 | 3,180,742 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $143,191,633 | 3,093,360 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $173,638,163 | 2,846,994 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $168,705,414 | 2,982,769 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $156,887,268 | 3,032,224 | Shares | Defined | 2024-10-25 | |
| 2024-06-30 | $144,306,283 | 3,474,748 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $201,681,531 | 3,719,003 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $199,766,247 | 3,893,320 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $176,643,636 | 3,043,481 | Shares | Defined | 2023-11-07 | |
| 2023-06-30 | $206,064,165 | 3,222,270 | Shares | Defined | 2024-06-20 | |
| 2023-03-31 | $217,432,121 | 3,137,096 | Shares | Defined | 2024-06-20 | |
| 2022-12-31 | $231,962,193 | 3,223,936 | Shares | Defined | 2024-06-20 | |
| 2022-09-30 | $229,649,845 | 3,230,410 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $224,211,064 | 2,911,832 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $201,361,599 | 2,757,245 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $190,334,844 | 3,052,684 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $283,600,623 | 4,792,980 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $364,738,571 | 5,458,524 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $342,250,706 | 5,421,364 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $291,269,368 | 4,695,621 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $281,306,022 | 4,665,882 | Shares | Defined | 2020-10-21 | |
| 2020-06-30 | $269,319,816 | 4,580,269 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $267,608,851 | 4,801,020 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||